Inteliview
Log inSign up
IPO Tracker
N

Norient Acquisition

Norient Acquisition

USPricing
Valuation$121M
Original Target2026-06-03 (Date under review)
Sector--
Exchange--
RELATED IPOS
Picard Medical, Inc.
Picard Medical, Inc.Picard Medical, Inc.US · --
I
Iron Dome Acquisition I Corp.Iron Dome Acquisition I Corp.US · --
A
Aperture ACAperture ACUS · --
HealthLynked Corp
HealthLynked CorpHealthLynked CorpUS · --
Onconetix, Inc.
Onconetix, Inc.Onconetix, Inc.US · --
Solidion Technology Inc.
Solidion Technology Inc.Solidion Technology Inc.US · --
FAQ

When is the Norient Acquisition IPO expected?

The Norient Acquisition IPO is currently in the Pricing stage. The originally expected date was 2026-06-03 and the process is ongoing. Timelines may change based on market conditions.

What is Norient Acquisition's valuation?

Norient Acquisition's estimated valuation is approximately $121M. The final valuation will depend on IPO pricing and market demand.

Can retail investors participate in the Norient Acquisition IPO?

U.S. IPOs are typically allocated to institutional investors first. Retail investors can purchase shares on NYSE/NASDAQ after listing. Some brokerages offer IPO access programs for pre-IPO allocation.